Research into cures for rare diseases needs a "hive mind" approach that includes deep collaboration among multiple stakeholders, backing by a philanthropic foundation and a focus on one specific condition, said Jonathan Silverstein of venture capital firm OrbiMed. "We can provide greater attention and speed, accelerating the process and moving science to medicine, from the lab to the patient, more rapidly," said Silverstein, who has Parkinson's disease with the rare GBA mutation.
Rare disease research needs to use a "hive mind" model
Sign up for FasterCures SmartBrief
Medical research news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.